Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Northrop Grumman Corporation filings document formal disclosures for an NYSE-listed aerospace and defense contractor with common stock trading under NOC. Recent 8-K reports furnish quarterly and annual earnings releases, summarize operating results and awards, and record material events such as director elections, officer transitions, compensation actions and credit-facility agreements.
The company's proxy materials describe board structure, committee assignments, executive compensation and annual meeting governance. Its financing disclosures cover senior unsecured revolving credit arrangements, commercial paper support, covenants, events of default and capital-structure terms relevant to the company's defense and space systems operations.
Northrop Grumman Corporation executive Roshan S. Roeder, CVP & President of Mission Systems, sold 512 shares of common stock in an open-market transaction on February 19, 2026 at an average price of $727.62 per share. This sale, totaling roughly $372,000, was executed under a pre-established Rule 10b5-1 trading plan adopted on October 30, 2025. After the sale, Roeder directly held 4,107.39 shares of common stock and had an additional 115.9204 shares held indirectly in the Northrop Grumman Savings Plan, where balances are based on units that can change without an actual share acquisition or disposition.
Northrop Grumman Corp (NOC) insider Michael A. Hardesty, Corporate Vice President, Controller and Chief Accounting Officer, reported an open-market sale of common stock. He sold 147 shares of Northrop Grumman common stock at a price of $732.98 per share on February 19, 2026. Following this transaction, he directly owns 2,525.29 shares of the company’s common stock.
Northrop Grumman director Christopher W. Grady reported an equity award of common stock under the company’s long-term incentive program. On February 12, 2026, he acquired 71 shares of common stock at a reported price of $695.06 per share in a transaction categorized as a grant or award.
According to the disclosure, these shares were deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan, in a transaction exempt under Rule 16b-3. Following this award, Grady’s directly held stock unit account reflected 71 shares of common stock equivalents pursuant to the plan.
Northrop Grumman director Christopher W. Grady filed an initial ownership report showing no direct holdings of the company’s common stock. The Form 3 indicates that, following the reported position, he owned 0 shares of Northrop Grumman common stock directly and reported no purchase or sale activity in this filing.
Northrop Grumman executive Benjamin R. Davies, Corporate Vice President and President of Defense Systems, reported several stock transactions. He sold 2,189.04 shares of common stock in an open‑market sale at a weighted average price of $719.61 per share, leaving 151 shares held directly.
On the prior day, 274 restricted stock rights were exercised into the same number of common shares, and 123 shares were withheld at $701.12 per share to cover tax obligations. Davies now holds 6,444 restricted stock rights that are scheduled to vest in stages between 2026 and 2029.
Northrop Grumman executive Robert J. Fleming reported equity award activity involving restricted stock rights and common shares. On 2/17/26, 264 Restricted Stock Rights were exercised, issuing 264 shares of common stock at a stated price of $0.0000 per share, reflecting the vesting of prior awards. In a related tax-withholding transaction, 85 common shares were disposed of at $701.12 per share to cover tax obligations, rather than through an open-market sale.
Following these transactions, Fleming directly held 2,619.03 shares of Northrop Grumman common stock. He also held 6,513 Restricted Stock Rights, which include grants under the company’s long-term incentive plans scheduled to vest on future dates.
Northrop Grumman corporate vice president, controller and chief accounting officer Michael A. Hardesty reported multiple share transactions on February 17, 2026. He acquired 538 Restricted Stock Rights that converted into 538 common shares at no cost upon vesting, then disposed of 243 shares to cover taxes and sold 715.94 shares in an open-market transaction at $700.63 per share, leaving him with 2,672.29 common shares directly owned. Footnotes note these shares vested from awards granted under the company’s long-term incentive stock plans and that additional Restricted Stock Rights remain scheduled to vest in later years.
Northrop Grumman executive Thomas H. Jones, CVP & President Aeronautics Systems, reported equity award activity tied to long-term incentives. On February 17, 2026, 2,152 Restricted Stock Rights (RSRs) vested and converted into an equivalent number of common shares at no exercise price under prior awards.
In connection with this vesting, 1,005 common shares were disposed of at $701.12 per share to cover tax obligations through share withholding, rather than an open-market sale. After these transactions, Jones directly held 11,204.715 common shares, plus 6,513 RSRs scheduled to vest between 2027 and 2029 under the company’s long-term incentive plans.
Northrop Grumman Chair, CEO and President Kathy J. Warden exercised 10,760 Restricted Stock Rights, receiving the same number of common shares at a stated price of $0.00 per share upon vesting on February 17, 2026. To cover tax obligations, 4,857 common shares were disposed of at $701.12 per share through a tax-withholding transaction, leaving her with 196,680.56 directly owned common shares after these transactions. The Restricted Stock Rights and shares were granted under the company’s long-term incentive stock plans and vest on specified future dates.
Northrop Grumman corporate VP and general counsel Kathryn G. Simpson reported several equity transactions in company stock. On February 17, 2026 she exercised 387 Restricted Stock Rights, receiving 387 common shares at a stated price of $0 per share. Of these, 193 shares were disposed of at $701.12 per share to cover tax obligations, and 779 shares were sold in an open-market transaction at $702.56 per share under a Rule 10b5-1 trading plan adopted on February 28, 2025. After these transactions, she directly held 1,068.39 common shares.